2023 annual financial data
Dyne Therapeutics, Inc. 2023 Operating margin
Dyne Therapeutics, Inc. 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -242,162,000 USD and net income was -235,937,000 USD.
Operating cash flow was -188,158,000 USD.
Get free Dyne Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -242,162,000 USD
- Net income
- -235,937,000 USD
- Operating cash flow
- -188,158,000 USD